Cited by 6,873HIV/AIDS Research and InterventionsHIV Research and TreatmentHIV/AIDS drug development and treatment

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Prevention of HIV-1 infection with early antiretroviral therapy.

Open access

Cohen, Myron S., Chen, Ying Q., McCauley, Marybeth, Gamble, Theresa, Hosseinipour, Mina C., Kumarasamy, Nagalingeswaran, Hakim, James G., Kumwenda, Johnstone, Grinsztejn, Beatriz, Pilotto, Jose H.S., Godbole, Sheela V., Mehendale, Sanjay, Chariyalertsak, Suwat, Santos, Breno R., Mayer, Kenneth H., Hoffman, Irving F., Eshleman, Susan H., Piwowar-Manning, Estelle, Wang, Lei, Makhema, Joseph, Mills, Lisa A., de Bruyn, Guy, Sanne, Ian, Eron, Joseph, Gallant, Joel, Havlir, Diane, Swindells, Susan, Ribaudo, Heather, Elharrar, Vanessa, Burns, David, Taha, Taha E., Nielsen-Saines, Karin, Celentano, David, Essex, Max, Fleming, Thomas R.·2011·New England Journal of Medicine

DOI 10.1056/nejmoa1105243PMC PMC3200068

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Antiretroviral therapy that reduces viral replication could limit the transmission of human immunodeficiency virus type 1 (HIV-1) in serodiscordant couples. METHODS: In nine countries, we enrolled 1763 couples in which one partner was HIV-1-positive and the other was HIV-1-negative; 54% of the subjects were from Africa, and 50% of infected partners were men. HIV-1-infected subjects with CD4 counts between 350 and 550 cells per cubic millimeter were randomly assigned in a 1:1 ratio to receive antiretroviral therapy either immediately (early therapy) or after a decline in the CD4 count or the onset of HIV-1-related symptoms (delayed therapy). The primary prevention end point was linked HIV-1 transmission in HIV-1-negative partners. The primary clinical end point was the earliest occurrence of pulmonary tuberculosis, severe bacterial infection, a World Health Organization stage 4 event, or death. RESULTS: As of February 21, 2011, a total of 39 HIV-1 transmissions were observed (incidence rate, 1.2 per 100 person-years; 95% confidence interval [CI], 0.9 to 1.7); of these, 28 were virologically linked to the infected partner (incidence rate, 0.9 per 100 person-years, 95% CI, 0.6 to 1.3). Of the 28 linked transmissions, only 1 occurred in the early-therapy group (hazard ratio, 0.04; 95% CI, 0.01 to 0.27; P<0.001). Subjects receiving early therapy had fewer treatment end points (hazard ratio, 0.59; 95% CI, 0.40 to 0.88; P=0.01). CONCLUSIONS: The early initiation of antiretroviral therapy reduced rates of sexual transmission of HIV-1 and clinical events, indicating both personal and public health benefits from such therapy. (Funded by the National Institute of Allergy and Infectious Diseases and others; HPTN 052 ClinicalTrials.gov number, NCT00074581.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1105243

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Self-citation
Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1
Quinn, T. C., Wawer, M. J., Sewankambo, N. K., Serwadda, D., Li, C., Wabwire‐Mangen, F., Meehan, M. O., Lutalo, T., & Gray, R. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421303 · Cited by 2,990
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
Granich, R., Gilks, C. F., Dye, C., Cock, K. M. D., & Williams, B. G. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61697-9 · Cited by 1,987
Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.
Wawer, M. J., Gray, R. H., Sewankambo, N. K., Serwadda, D., Li, X., Laeyendecker, O., Kiwanuka, N., Kigozi, G., Kiddugavu, M., Lutalo, T., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/429411 · Cited by 1,258
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries
Braitstein, P. K. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68337-2 · Cited by 1,106
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
Kitahata, M. M., Gange, S. J., Abraham, A. G., Merriman, B., Saag, M. S., Justice, A. C., Hogg, R. S., Deeks, S. G., Eron, J. J., Brooks, J. T., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807252 · Cited by 1,105
Self-citation
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
Donnell, D. J., Baeten, J. M., Kiarie, J. N., Thomas, K. K., Stevens, W. S., Cohen, C. R., McIntyre, J. A., Lingappa, J. R., & Celum, C. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60705-2 · Cited by 970
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study
Montaner, J. S., Lima, V. D., Barrios, R., Yip, B., Wood, E., Kerr, T., Shannon, K., Harrigan, P. R., Hogg, R. S., Daly, P., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60936-1 · Cited by 780
Decreases in Community Viral Load Are Accompanied by Reductions in New HIV Infections in San Francisco
Das, M., Chu, P. L., Santos, G., Scheer, S., Vittinghoff, E., McFarland, W., & Colfax, G. N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011068 · Cited by 771
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies
Sterne, J. A. C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60612-7 · Cited by 748

Flagged first, then by citations

Show all 35 references

Research works printed but not linked: 1

Smith K, 2011, Curr Opin HIV AIDS, 6, 315

Sorted by citations

Items 301–400 of 1,024

Effect of Micronutrient Supplementation on Disease Progression in Asymptomatic, Antiretroviral-Naive, HIV-Infected Adults in Botswana
Baum, M. K., Campa, A. L., Lai, S., Martínez, S. S., Tsalaile, L., Burns, P. J., Farahani, M., Li, Y., van Widenfelt, E., Page, J. B., et al. (2013) · JAMA · doi:10.1001/jama.2013.280923 · Cited by 121
Self-citation
Systematic review of facility-based sexual and reproductive health services for female sex workers in Africa
Dhana, A. V., Luchters, S. M. F., Moore, L., Lafort, Y., Roy, A., Scorgie, F., & Chersich, M. (2014) · Globalization and Health · doi:10.1186/1744-8603-10-46 · Cited by 121
Characterizing HIV Transmission Networks Across the United States
Aldous, J. L., Pond, S. L. K., Poon, A. F. Y., Jain, S., Qin, H., Kahn, J. S., Kitahata, M. M., Rodriguez, B. A., Dennis, A. M., Boswell, S., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis612 · Cited by 119
Barriers and Facilitators to Interventions Improving Retention in HIV Care: A Qualitative Evidence Meta-Synthesis
Hall, B. J., Sou, K.-L., Beanland, R. L., Lackey, M. J., Tso, L. S., Ma, Q., Doherty, M. C., & Tucker, J. D. (2016) · AIDS and Behavior · doi:10.1007/s10461-016-1537-0 · Cited by 121
Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial
Baeten, J. M., Donnell, D. J., Mugo, N., Ndase, P., Thomas, K. K., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70937-5 · Cited by 126
Women Who Use or Inject Drugs
El‐Bassel, N., & Strathdee, S. A. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000628 · Cited by 120
Twenty Years Of Antiretroviral Therapy For People Living With HIV: Global Costs, Health Achievements, Economic Benefits
Forsythe, S., McGreevey, W. P., Whiteside, A. W., Shah, M., Cohen, J., Hecht, R., Bollinger, L. A., & Kinghorn, A. (2019) · Health Affairs · doi:10.1377/hlthaff.2018.05391 · Cited by 120
Prevalence of undiagnosed HIV infection among persons aged ≥13 years--National HIV Surveillance System, United States, 2005-2008.
Chen, M., Rhodes, P., Hall, I., Kilmarx, P. H., Branson, B. M., & Valleroy, L. A. (2012) · PubMed · Cited by 119
U.S. Trends in Antiretroviral Therapy Use, HIV RNA Plasma Viral Loads, and CD4 T-Lymphocyte Cell Counts Among HIV-Infected Persons, 2000 to 2008
Althoff, K. N., Buchacz, K. A., Hall, H. I., Zhang, J., Hanna, D. B., Rebeiro, P. F., Gange, S. J., Moore, R. D., Kitahata, M. M., Gebo, K. A., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-5-201209040-00005 · Cited by 119
Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study
Babiker, A. G., Emery, S., Fätkenheuer, G., Gordin, F. M., Grund, B., Lundgren, J. D., Neaton, J. D., Pett, S. L., Phillips, A. N., Touloumi, G., et al. (2012) · Clinical Trials · doi:10.1177/1740774512440342 · Cited by 119
Illicit drug use and its association with sexual risk behaviour among MSM
Meléndez‐Torres, G. J., & Bourne, A. H. (2015) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000234 · Cited by 118
M-health for health behaviour change in resource-limited settings: applications to HIV care and beyond
Thirumurthy, H., & Lester, R. (2012) · Bulletin of the World Health Organization · doi:10.2471/blt.11.099317 · Cited by 109
In A Study Of A Population Cohort In South Africa, HIV Patients On Antiretrovirals Had Nearly Full Recovery Of Employment
Bor, J. H., Tanser, F. C., Newell, M., & Bärnighausen, T. (2012) · Health Affairs · doi:10.1377/hlthaff.2012.0407 · Cited by 118
High Rates of Retention and Viral Suppression in the US HIV Safety Net System: HIV Care Continuum in the Ryan White HIV/AIDS Program, 2011
Doshi, R. K., MILBERG, J. A., Isenberg, D., Matthews, T., Malitz, F. E., Matosky, M., Trent-Adams, S., Hopson, D. P., & Cheever, L. W. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu722 · Cited by 118
Antiretroviral therapy enrollment characteristics and outcomes among HIV-infected adolescents and young adults compared with older adults--seven African countries, 2004-2013.
Auld, A. F., Agolory, S. G., Shiraishi, R. W., Wabwire‐Mangen, F., Kwesigabo, G., Mulenga, M., Hachizovu, S., Asadu, E. C., Tuho, M. Z., Ettiègne-Traoré, V., et al. (2014) · PubMed Central · Cited by 118
Food Insecurity Is Associated with Increased Risk of Non-Adherence to Antiretroviral Therapy among HIV-Infected Adults in the Democratic Republic of Congo: A Cross-Sectional Study
Musumari, P. M., Wouters, E., Kayembe, P. K., Nzita, M. K., Mbikayi, S. M., Suguimoto, S. P., Techasrivichien, T., Lukhele, B. W., El-saaidi, C., Piot, P. K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085327 · Cited by 117
Demographic patterns of HIV testing uptake in sub-Saharan Africa
Staveteig, S. E., Wang, S., Head, S. K., Bradley, S., & Nybro, E. (2013) · Cited by 117
A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial
Hayes, R., Floyd, S., Schaap, A., Shanaube, K., Bock, P., Sabapathy, K., Griffith, S., Donnell, D. J., Piwowar‐Manning, E., El-Sadr, W. M., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002292 · Cited by 117
Self-citation
Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention
Stephenson, K. E., Wagh, K., Korber, B., & Barouch, D. H. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-080219-023629 · Cited by 118
HIV testing and linkage to services for youth
Kurth, A., Lally, M., Choko, A. T., Inwani, I. W., & Fortenberry, J. D. (2015) · Journal of the International AIDS Society · doi:10.7448/ias.18.2.19433 · Cited by 124
Continuous Retention and Viral Suppression Provide Further Insights Into the HIV Care Continuum Compared to the Cross-sectional HIV Care Cascade
Colasanti, J. A., Kelly, J., Pennisi, E., Hu, Y., Root, C., Hughes, D., del Rı́o, C., & Armstrong, W. S. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ941 · Cited by 116
The HIV care cascade: a systematic review of data sources, methodology and comparability
Medland, N., McMahon, J. H., Chow, E. P. F., Elliott, J., Hoy, J., & Fairley, C. K. (2015) · Journal of the International AIDS Society · doi:10.7448/ias.18.1.20634 · Cited by 116
Sources of HIV infection among men having sex with men and implications for prevention
Ratmann, O., van Sighem, A., Bezemer, D., Gavryushkina, A. “., Jurriaans, S., Wensing, A. M. J., de Wolf, F., Reiss, P., Fraser, C., & cohort, A. O. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad1863 · Cited by 116
The WHO public health approach to HIV treatment and care: looking back and looking ahead
Ford, N. P., Ball, A. L., Baggaley, R. C., Vitória, M., Low‐Beer, D., Penazzato, M., Vojnov, L., Bertagnolio, S., Habiyambere, V., Doherty, M. C., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30482-6 · Cited by 116
Opportunities and Challenges for Cost-Efficient Implementation of New Point-of-Care Diagnostics for HIV and Tuberculosis
Schito, M. L., Peter, T. F., Cavanaugh, S., Piatek, A. S., Young, G. J., Alexander, H. L., Coggin, W. L., Domingo, G. J., Ellenberger, D., Ermantraut, E., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis044 · Cited by 115
Partner Disclosure of PrEP Use and Undetectable Viral Load on Geosocial Networking Apps
Newcomb, M. E., Mongrella, M. C., Weis, B., McMillen, S. J., & Mustanski, B. S. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000819 · Cited by 119
Progress with Scale-Up of HIV Viral Load Monitoring — Seven Sub-Saharan African Countries, January 2015–June 2016
Lecher, S. L., Williams, J., Fonjungo, P. N., Kim, A. A., Ellenberger, D. L., Zhang, G., Adjé-Touré, C., Agolory, S. G., Appiah-Pippim, G., Beard, S., et al. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6547a2 · Cited by 115
Challenges Facing a Rural Opioid Epidemic: Treatment and Prevention of HIV and Hepatitis C
Schranz, A. J., Barrett, J., Hurt, C. B., Malvestutto, C., & Miller, W. C. (2018) · Current HIV/AIDS Reports · doi:10.1007/s11904-018-0393-0 · Cited by 118
Identifying At-Risk Populations in Kenya and South Africa
Price, M. A., RIDA, W. N., Mwangome, M. N., Mutua, G. N., Middelkoop, K., Roux, S., Okuku, H. S., Bekker, L., Anzala, O. A., NGUGI, E. N., et al. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31823d8693 · Cited by 112
Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial
Iwuji, C. C., Orne‐Gliemann, J., Tanser, F. C., Boyer, S., Lessells, R. J., Lert, F., Imrie, J. C., Bärnighausen, T., Rekacewicz, C., Bazin, B., et al. (2013) · Trials · doi:10.1186/1745-6215-14-230 · Cited by 114
Improvements in HIV Care Engagement and Viral Load Suppression Following Enrollment in a Comprehensive HIV Care Coordination Program
Irvine, M. K., Chamberlin, S., Robbins, R. S., Myers, J. E., Braunstein, S., Mitts, B., Harriman, G., & Nash, D. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu783 · Cited by 114
Common roots: a contextual review of HIV epidemics in black men who have sex with men across the African diaspora
Millett, G. A., Jeffries, W. L., Peterson, J. L., Malebranche, D. J., Lane, T., Flores, S. A., Fenton, K. A., Wilson, P. A., Steiner, R. J., & Heilig, C. M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60722-3 · Cited by 116
Status and methodology of publicly available national HIV care continua and 90-90-90 targets: A systematic review
Granich, R., Gupta, S., Hall, I., Aberle-Grasse, J. M., Hader, S., & Mermin, J. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002253 · Cited by 114
HIV treatment in pregnancy
Bailey, H., Zash, R., Rasi, V., & Thorne, C. (2018) · The Lancet HIV · doi:10.1016/s2352-3018(18)30059-6 · Cited by 114
Expert consensus statement on the science of HIV in the context of criminal law
Barré‐Sinoussi, F., Karim, S. S. A., Albert, J., Bekker, L., Beyrer, C., Cahn, P. E., Calmy, A., Grinsztejn, B. G. J., Grulich, A. E., Kamarulzaman, A., et al. (2018) · Journal of the International AIDS Society · doi:10.1002/jia2.25161 · Cited by 124
Self-citation
Individual and Network Factors Associated With Racial Disparities in HIV Among Young Men Who Have Sex With Men: Results From the RADAR Cohort Study
Mustanski, B. S., Morgan, E., D’Aquila, R. T., Birkett, M. A., Janulis, P. F., & Newcomb, M. E. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001886 · Cited by 114
Rapid HIV Viral Load Suppression in those Initiating Antiretroviral Therapy at First Visit after HIV Diagnosis
Hoenigl, M., Chaillon, A., Moore, D. J., Morris, S., Mehta, S. R., Gianella, S., Amico, K. R., & Little, S. J. (2016) · Scientific Reports · doi:10.1038/srep32947 · Cited by 113
Complex immune correlates of protection in HIV ‐1 vaccine efficacy trials
Tomaras, G. D., & Plotkin, S. A. (2017) · Immunological Reviews · doi:10.1111/imr.12514 · Cited by 113
Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples With Apples
Lodi, S., Phillips, A. N., Lundgren, J. D., Logan, R. W., Sharma, S., Cole, S. R., Babiker, A. G., Law, M. G., Chu, H., Byrne, D. D., et al. (2019) · American Journal of Epidemiology · doi:10.1093/aje/kwz100 · Cited by 113
Housing Status and the Health of People Living with HIV/AIDS
Milloy, M., Marshall, B. D. L., Montaner, J. S. G., & Wood, E. (2012) · Current HIV/AIDS Reports · doi:10.1007/s11904-012-0137-5 · Cited by 111
Challenges of infectious diseases in the USA
KHABBAZ, R. F., Moseley, R. R., Steiner, R. J., Levitt, A. M., & Bell, B. P. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60890-4 · Cited by 115
“You are wasting our drugs”: health service barriers to HIV treatment for sex workers in Zimbabwe
Mtetwa, S., Busza, J. R., Chidiya, S., Mungofa, S., & Cowan, F. M. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-698 · Cited by 112
Cost and quality of life analysis of HIV self-testing and facility-based HIV testing and counselling in Blantyre, Malawi
Maheswaran, H., Petrou, S., MacPherson, P., Choko, A. T., Kumwenda, F., Lalloo, D. G., Clarke, A., & Corbett, E. L. (2016) · BMC Medicine · doi:10.1186/s12916-016-0577-7 · Cited by 111
Systematic review of mobile health behavioural interventions to improve uptake of HIV testing for vulnerable and key populations
Conserve, D. F., Mayo‐Wilson, L. J., de Aguiar, C. G., Shin, G. D., Handler, L., & Maman, S. (2016) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x16639186 · Cited by 110
Trends in Sexual Behavior Among Men Who have Sex with Men (MSM) in High-Income Countries, 1990–2013: A Systematic Review
Hess, K. L., Crepaz, N., Rose, C. E., Purcell, D. W., & Paz‐Bailey, G. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1799-1 · Cited by 123
Da evidência à ação: desafios do Sistema Único de Saúde para ofertar a profilaxia pré-exposição sexual (PrEP) ao HIV às pessoas em maior vulnerabilidade
Zucchi, E. M., Grangeiro, A., Ferraz, D., Pinheiro, T. F., Alencar, T., Ferguson, L., Estevam, D. L., & Munhoz, R. (2018) · Cadernos de Saúde Pública · doi:10.1590/0102-311x00206617 · Cited by 130
Optima
Kerr, C. C., Stuart, R. M., Gray, R. T., Shattock, A. J., Fraser‐Hurt, N., Benedikt, C. J., Haacker, M., Berdnikov, M., Mahmood, A. M., Jaber, S. A., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000605 · Cited by 111
Analysis of Genetic Linkage of HIV From Couples Enrolled in the HIV Prevention Trials Network 052 Trial
Eshleman, S. H., Hudelson, S. E., Redd, A. D., Wang, L., Debes, R., Chen, Y. Q., Martens, C., Ricklefs, S., Selig, E. J., Porcella, S. F., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir651 · Cited by 111
Self-citation
HIV Testing Among US High School Students and Young Adults
Handel, M. M. V., Kann, L. K., Olsen, E. O., & Dietz, P. M. (2016) · PEDIATRICS · doi:10.1542/peds.2015-2700 · Cited by 115
Risk of sexual transmission of human immunodeficiency virus with antiretroviral therapy, suppressed viral load and condom use: a systematic review
LeMessurier, J., Traversy, G., Varsaneux, O., Weekes, M., Avey, M. T., Niragira, O., Gervais, R., Guyatt, G. H., & Rodin, R. (2018) · Canadian Medical Association Journal · doi:10.1503/cmaj.180311 · Cited by 114
Recent advances in carbon quantum dots for virus detection, as well as inhibition and treatment of viral infection
Xue, Y., Liu, C., Andrews, G., Wang, J., & Ge, Y. (2022) · Nano Convergence · doi:10.1186/s40580-022-00307-9 · Cited by 114
Retention in Care and Adherence to ART are Critical Elements of HIV Care Interventions
Stricker, S. M., Fox, K. A., Baggaley, R. C., Negussie, E. K., de Pee, S., Grede, N., & Bloem, M. W. (2013) · AIDS and Behavior · doi:10.1007/s10461-013-0598-6 · Cited by 114
Sexually transmitted hepatitis C infection
Bradshaw, D., Matthews, G. V., & Danta, M. (2012) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32835c2120 · Cited by 111
The Use of Cell Phone Support for Non-adherent HIV-Infected Youth and Young Adults: An Initial Randomized and Controlled Intervention Trial
Belzer, M., Naar-king, S., Olson, J., Sarr, M., Thornton, S. E., Kahana, S. Y., Gaur, A., Clark, L., & The Adolescent Medicine Trials Network for Hivaids Interventions (2014) · Aids and Behavior · doi:10.1007/s10461-013-0661-3 · Cited by 115
Epidemiology of HIV in Latin America and the Caribbean
Boni, R. B. D., Veloso, V. G., & Grinsztejn, B. G. J. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000031 · Cited by 109
Self-citation
Antiretroviral therapy refusal among newly diagnosed HIV-infected adults
Katz, I. T., Essien, T., Marinda, E. T., Gray, G., Bangsberg, D. R., Martinson, N. A., & de Bruyn, G. (2011) · AIDS · doi:10.1097/qad.0b013e32834b6464 · Cited by 110
Applying Public Health Principles to the HIV Epidemic — How Are We Doing?
Frieden, T. R., Foti, K. E., & Mermin, J. (2015) · New England Journal of Medicine · doi:10.1056/nejmms1513641 · Cited by 113
Challenges of HIV diagnosis and management in the context of pre‐exposure prophylaxis (PrEP), post‐exposure prophylaxis (PEP), test and start and acute HIV infection: a scoping review
Elliott, T., Sanders, E. J., Doherty, M. C., Ndung’u, T., Cohen, M. S., Patel, P., Cairns, G., Rutstein, S. E., Ananworanich, J., Brown, C. S., et al. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25419 · Cited by 110
Self-citation
Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial
Pollard, R. B., Rockstroh, J. K., Pantaleo, G., Asmuth, D. M., Peters, B. S., Lazzarin, A., García, F., Ellefsen, K., Podzamczer, D., van Lunzen, J., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70343-8 · Cited by 109
Ending the HIV–AIDS Pandemic — Follow the Science
Fauci, A. S., & Marston, H. D. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1502020 · Cited by 109
The Presentation, Diagnosis, and Treatment of Sexually Transmitted Infections
Wagenlehner, F. R. A., Brockmeyer, N. H., Discher, T., Friese, K., & Wichelhaus, T. A. (2016) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2016.0011 · Cited by 109
Emerging Technologies for Point-of-Care Management of HIV Infection
Shafiee, H., Wang, S., İnci, F., Toy, M., Henrich, T. J., Kuritzkes, D. R., & Demirci, U. (2014) · Annual Review of Medicine · doi:10.1146/annurev-med-092112-143017 · Cited by 109
The Problem of Late ART Initiation in Sub-Saharan Africa: A Transient Aspect of Scale-up or a Long-term Phenomenon?
Lahuerta, M., Ue, F., Hoffman, S., Elul, B., Kulkarni, S., Wu, Y., Nuwagaba‐Biribonwoha, H., Remien, R. H., El‐Sadr, W., & Nash, D. (2013) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.2013.0014 · Cited by 111
HIV treatment cascade among transgender women in a San Francisco respondent driven sampling study
Santos, G., Wilson, E. C., Rapues, J., Macías, Ó., Packer, T., & Raymond, H. F. (2014) · Sexually Transmitted Infections · doi:10.1136/sextrans-2013-051342 · Cited by 108
Preventing HIV Among Young People
Pettifor, A. E., Bekker, L., Hosek, S., DiClemente, R. J., Rosenberg, M. S., Bull, S. S., Allison, S. M., Delany‐Moretlwe, S., Kapogiannis, B. G., & Cowan, F. M. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31829871fb · Cited by 117
Antenatal care and uptake of HIV testing among pregnant women in sub‐Saharan Africa: a cross‐sectional study
Gunn, J. K. L., Asaolu, I. O., Gibson, S. J., Wightman, P. D., Ezeanolue, E. E., & Ehiri, J. E. (2016) · Journal of the International AIDS Society · doi:10.7448/ias.19.1.20605 · Cited by 113
Reliability and Validity of Depression Assessment Among Persons With HIV in Sub-Saharan Africa
Tsai, A. C. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000210 · Cited by 109
Meta-Analysis of Studies Comparing Single and Multi-Tablet Fixed Dose Combination HIV Treatment Regimens
Clay, P. G., Nag, S., Graham, C. M., & Narayanan, S. (2015) · Medicine · doi:10.1097/md.0000000000001677 · Cited by 109
An Equilibrium Model of the African HIV/AIDS Epidemic
Greenwood, J., Kircher, P., Santos, C., & Tertilt, M. (2013) · Econometrica · doi:10.3982/ecta11530 · Cited by 118
Sexual behaviour of heterosexual men and women receiving antiretroviral pre-exposure prophylaxis for HIV prevention: a longitudinal analysis
Mugwanya, K. K., Donnell, D. J., Celum, C., Thomas, K. K., Ndase, P., Mugo, N., Katabira, E. T., Ngure, K., & Baeten, J. M. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70226-3 · Cited by 108
The HIV care continuum: no partial credit given.
McNairy, M., & El-Sadr, W. (2012) · AIDS (London) · doi:10.1097/qad.0b013e328355d67b · Cited by 124
Gender, HIV Testing and Stigma: The Association of HIV Testing Behaviors and Community-Level and Individual-Level Stigma in Rural South Africa Differ for Men and Women
Treves-Kagan, S., Ayadi, A. M. E., Pettifor, A. E., MacPhail, C. L., Twine, R., Maman, S., Peacock, D., Kahn, K., & Lippman, S. A. (2017) · AIDS and Behavior · doi:10.1007/s10461-016-1671-8 · Cited by 106
Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa
Heffron, R. A., Ngure, K., Odoyo, J. B., Bulya, N., Tindimwebwa, E., Hong, T., Kidoguchi, L., Donnell, D. J., Mugo, N., Bukusi, E. A., et al. (2017) · Gates Open Research · doi:10.12688/gatesopenres.12752.2 · Cited by 104
West Nile Virus and Other Arboviral Diseases—United States, 2013
Lindsey, N. P., Lehman, J. A., Staples, J. E., & Fischer, M. (2014) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000490 · Cited by 106
Addressing the Achilles' Heel in the HIV Care Continuum for the Success of a Test-and-Treat Strategy to Achieve an AIDS-Free Generation
Nachega, J. B., Uthman, O. A., del Rı́o, C., Mugavero, M. J., Rees, H., & Mills, E. J. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu299 · Cited by 107
Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling study
Nichols, B. E., Boucher, C. A., van der Valk, M., Rijnders, B. J. A., & van de Vijver, D. A. M. C. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30311-5 · Cited by 107
Effectiveness and cost-effectiveness of a nurse-delivered intervention to improve adherence to treatment for HIV: a pragmatic, multicentre, open-label, randomised clinical trial
de Bruin, M., Oberjé, E. J. M., Viechtbauer, W., Nobel, H., Hiligsmann, M., van Nieuwkoop, C., Veenstra, J., Pijnappel, F. J. J., Kroon, F. P., van Zonneveld, L., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30534-5 · Cited by 105
Dynamics of the HIV outbreak and response in Scott County, IN, USA, 2011–15: a modelling study
Gonsalves, G., & Crawford, F. W. (2018) · The Lancet HIV · doi:10.1016/s2352-3018(18)30176-0 · Cited by 105
Burden and changes in HIV/AIDS morbidity and mortality in Southern Africa Development Community Countries, 1990–2017
Gona, P. N., Gona, C. M., Ballout, S., Rao, S. R., Kimokoti, R. W., Mapoma, C. C., & Mokdad, A. H. (2020) · BMC Public Health · doi:10.1186/s12889-020-08988-9 · Cited by 108
The HIV care cascade: models, measures and moving forward
MacCarthy, S., Hoffmann, M., Ferguson, L., Nunn, A. S., Irvin, R., Bangsberg, D. R., Gruskin, S., & Dourado, I. C. (2015) · Journal of the International AIDS Society · doi:10.7448/ias.18.1.19395 · Cited by 104
Factors associated with HIV viral load suppression on antiretroviral therapy in Vietnam
Rangarajan, S., Colby, D., Giang, L. T., Bui, D. D., Nguyen, H. H., Tou, P. B., Tran, D. T., Tran, N., Nguyen, D. A., Nguyễn, B. H., et al. (2016) · Journal of virus eradication · doi:10.1016/s2055-6640(20)30466-0 · Cited by 89
Addressing Gaps in HIV Preexposure Prophylaxis Care to Reduce Racial Disparities in HIV Incidence in the United States
Jenness, S. M., Maloney, K. M., Smith, D. K., Hoover, K. W., Goodreau, S. M., Rosenberg, E. S., Weiss, K. M., Liu, A., Rao, D. W., & Sullivan, P. S. (2018) · American Journal of Epidemiology · doi:10.1093/aje/kwy230 · Cited by 105
A Tale of Two Viruses: Immunological Insights Into HCV/HIV Coinfection
Gobran, S. T., Ancuța, P., & Shoukry, N. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.726419 · Cited by 105
Can hepatitis C virus infection be eradicated in people who inject drugs?
Grebely, J., & Dore, G. J. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.01.002 · Cited by 103
Current perspectives in HIV post-exposure prophylaxis
Benn, P. D., Sultan, B., & Waters, L. J. (2014) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s46585 · Cited by 109
Distinct HIV discordancy patterns by epidemic size in stable sexual partnerships in sub-Saharan Africa
Chemaitelly, H. S., Cremin, Í., Shelton, J., Hallett, T. B., & Abu-Raddad, L. J. (2012) · Sexually Transmitted Infections · doi:10.1136/sextrans-2011-050114 · Cited by 103
Advanced HIV Disease at Entry into HIV Care and Initiation of Antiretroviral Therapy During 2006-2011: Findings From Four Sub-Saharan African Countries
Lahuerta, M., Wu, Y., Hoffman, S., Elul, B., Kulkarni, S., Remien, R. H., Nuwagaba‐Biribonwoha, H., El-Sadr, W. M., & Nash, D. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit724 · Cited by 103
Progress in HIV vaccine development
Hsu, D. C., & O’Connell, R. J. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1276138 · Cited by 109
Improved life expectancy of people living with HIV: who is left behind?
Katz, I. T., & Maughan‐Brown, B. (2017) · The Lancet HIV · doi:10.1016/s2352-3018(17)30086-3 · Cited by 103
Estimating retention in HIV care accounting for patient transfers: A national laboratory cohort study in South Africa
Fox, M. P., Bor, J., Brennan, A. T., MacLeod, W. B., Maskew, M., Stevens, W. S., & Carmona, S. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002589 · Cited by 103
HIV in Canada—Surveillance Report, 2018
Haddad, N., Robert, A., Weeks, A., Popovic, N., Siu, W., & Archibald, C. P. (2019) · Canada Communicable Disease Report · doi:10.14745/ccdr.v45i12a01 · Cited by 103
Time and Money
Chimbindi, N., Bor, J. H., Newell, M., Tanser, F. C., Baltussen, R. M. P. M., Hontelez, J. A. C., de Vlas, S. J., Lurie, M. N., Pillay, D., & Bärnighausen, T. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000728 · Cited by 103
Alcohol Use and Sexual Risk Behaviors among Individuals Infected with HIV: A Systematic Review and Meta-Analysis 2012 to Early 2013
the MASH Research Team, Scott-Sheldon, L. A. J., Walstrom, P., Carey, K. B., Johnson, B. T., & Carey, M. P. (2013) · Current HIV/AIDS Reports · doi:10.1007/s11904-013-0177-5 · Cited by 104
“Just Because It's Out There, People Aren't Going to Use It.” HIV Self-Testing Among Young, Black MSM, and Transgender Women
Frye, V. A., Wilton, L., Hirshfield, S., Chiasson, M. A., Usher, D., Lucy, D., McCrossin, J., Greene, E., Koblin, B. A., & for the All About Me Study Team (2015) · AIDS Patient Care and STDs · doi:10.1089/apc.2015.0100 · Cited by 102
Uptake of Treatment as Prevention for HIV and Continuum of Care Among HIV-Positive Men Who Have Sex With Men in Nigeria
Charurat, M. E., Emmanuel, B., Akolo, C., Keshinro, B., Nowak, R. G., Kennedy, S., Orazulike, I., Ake, J. A., Njoku, O. S., Baral, S., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000439 · Cited by 101
Elimination of Hepatitis C Virus Infection Among People Who Inject Drugs Through Treatment as Prevention: Feasibility and Future Requirements
Grebely, J., Matthews, G. V., Lloyd, A. R., & Dore, G. J. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit377 · Cited by 102
A Framework for Elimination of Perinatal Transmission of HIV in the United States
Nesheim, S. R., Taylor, A. W., Lampe, M. A., Kilmarx, P. H., Harris, L. F. F., Whitmore, S. K., Griffith, J., Thomas-Proctor, M., Fenton, K. A., & Mermin, J. (2012) · PEDIATRICS · doi:10.1542/peds.2012-0194 · Cited by 102
Adherence to antiretroviral therapy for HIV / AIDS in Latin America and the Caribbean: Systematic review and meta‐analysis
Costa, J. D. M., Torres, T. S., Coelho, L. E., & Luz, P. M. (2018) · Journal of the International AIDS Society · doi:10.1002/jia2.25066 · Cited by 102
Conditional Economic Incentives to Improve HIV Treatment Adherence: Literature Review and Theoretical Considerations
Galárraga, O., Genberg, B. L., Martin, R. A., Laws, M. B., & Wilson, I. B. (2013) · AIDS and Behavior · doi:10.1007/s10461-013-0415-2 · Cited by 105
The first decade of antiretroviral therapy in Africa
Ford, N. P., Calmy, A., & Mills, E. J. (2011) · Globalization and Health · doi:10.1186/1744-8603-7-33 · Cited by 102

Authors: Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., Godbole, S. V., Mehendale, S., Chariyalertsak, S., Santos, B. R., Mayer, K. H., Hoffman, I. F., Eshleman, S. H., Piwowar-Manning, E., Wang, L., Makhema, J., Mills, L. A., de Bruyn, G., Sanne, I., Eron, J., Gallant, J., Havlir, D., Swindells, S., Ribaudo, H., Elharrar, V., Burns, D., Taha, T. E., Nielsen-Saines, K., Celentano, D., Essex, M., & Fleming, T. R.
Affiliations: University of North Carolina at Chapel Hill (US)
Fred Hutch Cancer Center (US)
YR Gaitonde Centre for AIDS Research and Education (IN)
University of Zimbabwe (ZW)
Johns Hopkins University (US)
National AIDS Research Institute (IN)
Chiang Mai University (TH)
Fenway Health (US)
Harvard University (US)
Kenya Medical Research Institute (KE)
University of California, San Francisco (US)
University of Nebraska Medical Center (US)
National Institutes of Health (US)
University of Washington (US)
ORCID: Cohen, Myron S.
Chen, Ying Q.
Gamble, Theresa
Hosseinipour, Mina C.
Kumarasamy, Nagalingeswaran
Hakim, James G.
Kumwenda, Johnstone
Grinsztejn, Beatriz
Godbole, Sheela V.
Mehendale, Sanjay
Chariyalertsak, Suwat
Santos, Breno R.
Mayer, Kenneth H.
Hoffman, Irving F.
Eshleman, Susan H.
Wang, Lei
Makhema, Joseph
Mills, Lisa A.
Sanne, Ian
Eron, Joseph
Gallant, Joel
Havlir, Diane
Swindells, Susan
Ribaudo, Heather
Burns, David
Taha, Taha E.
Celentano, David
Essex, Max
Fleming, Thomas R.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2011-08-11
Volume: 365
Issue: 6
Pages: 493-505
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1105243
PMC: PMC3200068
OpenAlex: W2152505869
Cited by: 6,873
References: 35
Citations by year: 2026: 106 · 2025: 155 · 2024: 189 · 2023: 204 · 2022: 288 · 2021: 354 · 2020: 398 · 2019: 471 · 2018: 510 · 2017: 594 · 2016: 694 · 2015: 720 · 2014: 759 · 2013: 740 · 2012: 571
FWCI: 466.60
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Arca - Repositório Institucional da Fiocruz (submittedVersion, other-oa)
Funders: Abbott Laboratories
Bristol-Myers Squibb
Pfizer
GlaxoSmithKline
Sanofi
Gilead Sciences
ViiV Healthcare
Abbott Diagnostics
Sanofi Pasteur
National Institute of Allergy and Infectious Diseases (U01AI068617, U01AI068619, U01AI068613, K24AI051982, UM1AI068619, UM1AI069418, P30AI050410, UM1AI068613, UM1AI068617, P30AI027763)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (R24HD042854)
Topics: Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords: HIV-1 prevention, early antiretroviral therapy, serodiscordant couples, sexual transmission of HIV, CD4 count, HIV-negative partners, tuberculosis, bacterial infection, AIDS mortality, HPTN 052
MeSH terms: Adolescent, Adult, Drug Therapy, Combination, Female, HIV Seropositivity, Humans, Male, Sexual Partners, HIV-1, HIV Infections, Proportional Hazards Models, Treatment Outcome, Disease Progression, Spouses, Disease Transmission, Infectious, Anti-Retroviral Agents, Kaplan-Meier Estimate, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prevention of HIV-1 infection with early antiretroviral therapy.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks